Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunomodulation by targeted anticancer agents
Giulia Petroni, Aitziber Buqué, Laurence Zitvogel, et al.
Cancer Cell (2020) Vol. 39, Iss. 3, pp. 310-345
Open Access | Times Cited: 181

Showing 51-75 of 181 citing articles:

Nanotechnology-based in situ cancer vaccines: Mechanisms, design, and recent advances
Gaoli Niu, Hong Wang, Yanhong Zhai, et al.
Nano Today (2024) Vol. 56, pp. 102286-102286
Closed Access | Times Cited: 7
Strategies to enhance the therapeutic efficacy of anti-PD-1 antibody, anti-PD-L1 antibody and anti-CTLA-4 antibody in cancer therapy
Xin Su, Jian Li, Xiao‐Ming Xu, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Pharmacological inhibitors of anaplastic lymphoma kinase (ALK) induce immunogenic cell death through on-target effects
Adriana Petrazzuolo, María Pérez-Lanzón, Isabel Martins, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 8
Open Access | Times Cited: 33
How Chemotherapy Affects the Tumor Immune Microenvironment: A Narrative Review
Marco Merlano, Nerina Denaro, Danilo Galizia, et al.
Biomedicines (2022) Vol. 10, Iss. 8, pp. 1822-1822
Open Access | Times Cited: 27
Molecular targeted therapy: A new avenue in glioblastoma treatment (Review)
Oula El Atat, Rayan Naser, Maya Abdelkhalek, et al.
Oncology Letters (2022) Vol. 25, Iss. 2
Open Access | Times Cited: 27
Immunological control of ovarian carcinoma by chemotherapy and targeted anticancer agents
Jitka Fučíková, Lenka Palová-Jelínková, Vanessa Klapp, et al.
Trends in cancer (2022) Vol. 8, Iss. 5, pp. 426-444
Open Access | Times Cited: 26
Oxygen microcapsules improve immune checkpoint blockade by ameliorating hypoxia condition in pancreatic ductal adenocarcinoma
Jiangchao Wu, Xun Wang, Li Chen, et al.
Bioactive Materials (2022) Vol. 20, pp. 259-270
Open Access | Times Cited: 26
Function and Application of Flavonoids in the Breast Cancer
Min Yeong Park, Yoonjung Kim, Sang Eun Ha, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 14, pp. 7732-7732
Open Access | Times Cited: 25
Type I interferon signaling in malignant blasts contributes to treatment efficacy in AML patients
Peter Holíček, Iva Truxová, Jana Raková, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 3
Open Access | Times Cited: 16
Durable responses to alectinib in murine models of EML4-ALK lung cancer requires adaptive immunity
Emily K. Kleczko, Trista K. Hinz, Teresa T. Nguyen, et al.
npj Precision Oncology (2023) Vol. 7, Iss. 1
Open Access | Times Cited: 14
Immune Checkpoint Inhibitor Associated Myocarditis and Cardiomyopathy: A Translational Review
Dong Wang, Johann Bauersachs, Dominik Berliner
Biology (2023) Vol. 12, Iss. 3, pp. 472-472
Open Access | Times Cited: 14
Medicinal Herbs: Promising Immunomodulators for the Treatment of Infectious Diseases
Hamad H. Alanazi, Abdelbaset Mohamed Elasbali, Maged K. Alanazi, et al.
Molecules (2023) Vol. 28, Iss. 24, pp. 8045-8045
Open Access | Times Cited: 14
A biologic-device combination product delivering tumor-derived antigens elicits immunogenic cell death-associated immune responses against glioblastoma
Christopher Cultrara, Christopher Uhl, Kenneth W. Kirby, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 8, pp. e006880-e006880
Open Access | Times Cited: 13
A new MVA ancestor-derived oncolytic vaccinia virus induces immunogenic tumor cell death and robust antitumor immune responses
Juan J. Rojas, Lien Van Hoecke, Miquel À. Conesa, et al.
Molecular Therapy (2024) Vol. 32, Iss. 7, pp. 2406-2422
Open Access | Times Cited: 5
Venetoclax acts as an immunometabolic modulator to potentiate adoptive NK cell immunotherapy against leukemia
Yan Wang, Beibei Huang, Tingting Liang, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 6, pp. 101580-101580
Open Access | Times Cited: 5
Enhanced radiotherapy efficacy and induced anti-tumor immunity in HCC by improving hypoxia microenvironment using oxygen microcapsules
Xiaomeng Dai, Jian Ruan, Yixuan Guo, et al.
Chemical Engineering Journal (2021) Vol. 422, pp. 130109-130109
Closed Access | Times Cited: 31
Combination Foretinib and Anti-PD-1 Antibody Immunotherapy for Colorectal Carcinoma
Yuyin Fu, Yujia Peng, Shengyan Zhao, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 30
Engineering prodrug nanomicelles as pyroptosis inducer for codelivery of PI3K/mTOR and CDK inhibitors to enhance antitumor immunity
Qi‐Chao Yang, Xianbin Ma, Yao Xiao, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 7, pp. 3139-3155
Open Access | Times Cited: 22
Local anesthetics elicit immune-dependent anticancer effects
Lucillia Bezu, Alejandra Wu Chuang, Allan Sauvat, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 4, pp. e004151-e004151
Open Access | Times Cited: 21
Trial Watch: combination of tyrosine kinase inhibitors (TKIs) and immunotherapy
Adriana Petrazzuolo, Maria Chiara Maiuri, Laurence Zitvogel, et al.
OncoImmunology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 21
Functionalized biomimetic nanoparticles combining programmed death-1/programmed death-ligand 1 blockade with photothermal ablation for enhanced colorectal cancer immunotherapy
Yuchen Xiao, Tianchuan Zhu, Qi Zeng, et al.
Acta Biomaterialia (2022) Vol. 157, pp. 451-466
Open Access | Times Cited: 21
DHODH inhibition enhances the efficacy of immune checkpoint blockade by increasing cancer cell antigen presentation
Nicholas J. Mullen, Surendra K. Shukla, Ravi Thakur, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 11
Radiopharmaceuticals as combinatorial partners for immune checkpoint inhibitors
Jean‐Pierre Pouget, Timothy A. Chan, Lorenzo Galluzzi, et al.
Trends in cancer (2023) Vol. 9, Iss. 11, pp. 968-981
Open Access | Times Cited: 11
Extracellular vesicles from Fusobacterium nucleatum : roles in the malignant phenotypes of gastric cancer
Xiangkun Meng, Gang Ma, Xu Zhang, et al.
Cell Cycle (2024) Vol. 23, Iss. 3, pp. 294-307
Closed Access | Times Cited: 4
Shifting the paradigm: engaging multicellular networks for cancer therapy
Joyce Hu, Paolo A. Ascierto, Alessandra Cesano, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4

Scroll to top